BIOTECH GROWTH TRUST (THE) PLC - Investor Presentation

In this episode, we examine the Biotech Growth Trust's 2025 sector outlook amid significant shifts in the biotech industry. Despite remarkable scientific advances, the sector has faced a historic market downturn, yet recently showed a notable rebound, with the trust's net asset value increasing by 69% in less than a year. We discuss key developments in drug therapies as well as the impact of stabilizing interest rates and political changes on the biotech market. The episode also highlights the rise of China in global biotech, which is reshaping clinical research and prompting Western pharmaceutical companies to adapt their strategies. Ultimately, we pose a critical question about the future of traditional pharmaceutical innovation in light of these trends.